CLINICAL STUDIES
Cancer incidence in the administrative centers of Siberia and the Russian Far East was first studied from1998 to 2012 years. Proportion of urban population ranged from 18.5 % in Kemerovo city to 56.0 % in Magadan city. During the study period, the incidence rate in the administrative centers of the region (259.1 ± 0.4 0/0000) was higher than in the whole region (233.0 ± 0.2 0/0000) (p<0.05). The lowest rates were observed in the Yakutsk city (206.8 ± 2.3 0/0000), Abakan city (212.1 ± 2.6 0/0000) and Kyzyl city (231.5 ± 4.2 0/0000), the largest rates were in Yuzhno-Sakhalinsk city (308.6 ± 3.1 0/0000), Irkutsk city (298.2 ± 1.6 0/0000) and Barnaul city (292.8 ± 1.5 0/0000). A significant rise in cancer incidence was observed among the urban population. The highest growth rates were noted in Irkutsk city (30.1 %), Petropavlovsk-Kamchatsky city (26.8 %), whereas the lowest rates were found in Kemerovo city (0.1 %) and Omsk city (0.3 %). Cluster analysis allowed the group of cities with low and high cancer risk to be identified.
The aim of the study was the assessment of tumor burden’s components (a mediastinum/thoracic ratio – MTR, peripheral bulky disease, and number of involved lymph nodes) in young adults with Hodgkin’s lymphoma and the analysis of their predictive value. Data on 87 patients aged from 19 till 29 years (median 24 ± 4 years) are submitted. The optimum cut-off level according ROC method for MTR has been established at 0.33, for peripheral bulky disease has been established at 46 mm, and for number of involved lymph nodes has been established at 5. Use of the correlation and regression analysis allocated the best linear regression model for MTR with the maximum determination coefficient and the minimum residual dispersion. There were statistically significant the equation by Fischer's criterion and determination coefficient (Ffact(46.74)>Ftheor(4.17)). Linear and nonlinear regression models for «a peripheral lymphadenopathy» and «number of involved zones» didn't show significant influence on the outcome (p=0.9237 and p=0.3385, respectively). MTR significant influenced the late results. The disease-free survival in patient’s group with MTR less than 0.33 was 100 %, in group with MTR more than 0.34 was 41 % (log-rank test 0.04649).
LABORATORY AND EXPERIMENTAL STUDIES
The aim of the study was to investigate the NF-κB, HIF-1 and VEGF expressions and the proteasome and calpain activities in localized and disseminated kidney cancers.
Material: The study included 87 patients with clear cell kidney cancer. Transcription factors and VEGF expression were measured by ELISA kits. Proteasome and calpain activity was determined using specific fluorogenic substrate.
Results. The increase of NF-κB, HIF-1 expression in cancer tissues is associated with the development of hematogenic metastasis. Coefficient NF-κB р65/р50, referred to the level of active transcription factor forms, had the wave-like pattern and was increased in cancer tissues with single metastases and decreased in cancer tissues with multiple ones. The same trend of VEGF changes was revealed in kidney tissues. The low proteasome activity in metastatic cancer tissues was observed. The changes in calpain activity had the same dynamics as the expression of NF-κB and VEGF.
Conclusion. The changes in NF-κB, HIF-1transcription factors, VEGF growth factor expressions and protease activities that could regulate their level, in localized and disseminated kidney cancer tissue were revealed. Coefficient NF-κB р65/р50, VEGF expression and proteases activities could be the potential prognostic molecular markers of hematogenic metastasis development in kidney cancer.
ONCOLOGY PRACTICE
REVIEWS
CASE REPORTS
JUBILEES
ISSN 2312-3168 (Online)